Literature DB >> 16636244

Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.

M-E Arsenault1, C Prévost, A Lescault, C Laberge, J Puymirat, J Mathieu.   

Abstract

The authors report a genotype-phenotype correlation study in 102 patients with myotonic dystrophy type 1 carrying small CTG repeat expansions. Most patients carrying 50 to 99 CTG repeats were asymptomatic, except for cataracts. Myotonia, weakness, excessive daytime sleepiness, and myotonic discharges at EMG were significantly more present in the patients with 100 to 200 CTG repeats. These findings highlight different outcomes related to the expansion size, even among small CTG expansions.

Entities:  

Mesh:

Year:  2006        PMID: 16636244     DOI: 10.1212/01.wnl.0000208513.48550.08

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Daytime sleepiness and myotonic dystrophy.

Authors:  Luc Laberge; Cynthia Gagnon; Yves Dauvilliers
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

2.  MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1.

Authors:  Vincent Huin; Francis Vasseur; Susanna Schraen-Maschke; Claire-Marie Dhaenens; Patrick Devos; Kathy Dupont; Nicolas Sergeant; Luc Buée; Arnaud Lacour; Hélène Hofmann-Radvanyi; Bernard Sablonnière
Journal:  J Neurol       Date:  2012-11-16       Impact factor: 4.849

3.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

4.  A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Émilie Petitclerc; Marie Kierkegaard; Jean Mathieu; Élise Duchesne; Luc J Hébert
Journal:  J Neurol       Date:  2018-05-21       Impact factor: 4.849

5.  Myotonic dystrophy type 1 presenting with dyspnea: A case report.

Authors:  Yu-Xi Jia; Chun-Ling Dong; Jia-Wei Xue; Xiao-Qin Duan; Ming-Yu Xu; Xiao-Min Su; Ping Li
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

6.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

7.  [Anticipation in patients with iridescent multicoloured posterior capsular lens opacities ("Christmas tree cataract") : The Role in the diagnosis of myotonic dystrophy].

Authors:  C Reiter; E Gramer
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

8.  Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.

Authors:  V Vinod Mootha; Brock Hansen; Ziye Rong; Pradeep P Mammen; Zhengyang Zhou; Chao Xing; Xin Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

9.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Authors:  Tiina Suominen; Linda L Bachinski; Satu Auvinen; Peter Hackman; Keith A Baggerly; Corrado Angelini; Leena Peltonen; Ralf Krahe; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2011-03-02       Impact factor: 4.246

Review 10.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.